# FDA recall D-609-2013

> **Pharmacia & Upjohn LLC** · Class II · drug recall initiated 2013-06-04.

## Product

Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, Distributed by Pharmacia & Upjohn Co, Division of Pfizer Inc, NY, NY 10017, NDC a) 0009-3124-03 and b) 0009-3447-03

## Reason for recall

Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-609-2013
- **Recalling firm:** Pharmacia & Upjohn LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-06-04
- **Report date:** 2013-06-26
- **Termination date:** 2014-04-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Kalamazoo, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-609-2013

## Citation

> AI Analytics. FDA recall D-609-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-609-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*